|
|
|
Insider
Information: |
Mott David M |
Relationship: |
Director |
City: |
Gaithersburg |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
36 |
|
Direct
Shares |
6,137,361 |
|
Indirect Shares
|
266,283,930 |
|
|
Direct
Value |
$8,800,265 |
|
|
Indirect Value
|
$1,035,299,275 |
|
|
Total
Shares |
272,421,291 |
|
|
Total
Value |
$1,044,099,540 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
Percentage
Gain/Loss : |
134.9%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Medimmune Inc |
MEDI |
Vice Chairman, CEO & P... |
2007-06-01 |
0 |
2003-09-15 |
0 |
Premium* |
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2011-11-21 |
0 |
2013-06-03 |
575 |
Premium* |
|
Millennial Media Inc |
MM |
10% Owner |
2012-04-03 |
0 |
2012-10-29 |
8,196,614 |
Premium* |
|
Tesaro, Inc. |
TSRO |
Director, 10% Owner |
2019-01-22 |
0 |
2019-01-22 |
0 |
Premium* |
|
Workday, Inc. |
WDAY |
10% Owner |
2013-04-09 |
0 |
2013-04-09 |
1,171 |
Premium* |
|
Interleukin Genetics Inc |
ILIU |
10% Owner |
|
0 |
2016-07-29 |
55,418,811 |
Premium* |
|
Epizyme, Inc. |
EPZM |
Director |
2022-08-12 |
0 |
2022-08-12 |
0 |
Premium* |
|
Care.com Inc |
CRCM |
10% Owner |
2014-01-29 |
0 |
2017-11-06 |
2,302 |
Premium* |
|
Roka Bioscience, Inc. |
ROKA |
10% Owner |
|
0 |
2014-07-22 |
3,216,810 |
Premium* |
|
Loxo Oncology, Inc. |
LOXO |
10% Owner |
2014-08-06 |
0 |
2014-08-06 |
1,789,420 |
Premium* |
|
Box Inc |
BOX |
10% Owner |
|
0 |
2015-01-28 |
0 |
Premium* |
|
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2015-02-04 |
0 |
2016-11-29 |
2,758,039 |
Premium* |
|
Champions Biotechnology Inc |
CSBR |
10% Owner |
|
0 |
2015-03-11 |
18,750,000 |
Premium* |
|
Ardelyx Inc |
ARDX |
Director |
2024-06-14 |
1,209,597 |
2019-12-09 |
6,564,372 |
Premium* |
|
Nuvelo Inc |
ABIO |
10% Owner |
|
0 |
2018-02-26 |
0 |
Premium* |
|
Synlogic Inc |
SYBX |
10% Owner |
2015-10-05 |
0 |
2018-01-26 |
4,228,940 |
Premium* |
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2015-10-20 |
0 |
2015-10-20 |
594,245 |
Premium* |
|
Adaptimmune Therapeutics PLC |
ADAP |
Director, 10% Owner |
|
0 |
2020-01-24 |
102,478,668 |
Premium* |
|
Aveo Pharmaceuticals Inc |
AVEO |
10% Owner |
|
0 |
2019-04-08 |
25,243,865 |
Premium* |
|
Achaogen Inc |
AKAO |
10% Owner |
|
0 |
2016-12-19 |
5,215,128 |
Premium* |
|
Ra Pharmaceuticals, Inc. |
RARX |
10% Owner |
2016-10-31 |
0 |
2016-10-31 |
3,490,073 |
Premium* |
|
Cascadian Therapeutics, Inc |
CASC |
10% Owner |
|
0 |
2018-03-09 |
0 |
Premium* |
|
Mulesoft, Inc |
MULE |
10% Owner |
|
0 |
2018-05-01 |
0 |
Premium* |
|
Mersana Therapeutics, Inc. |
MRSN |
Director |
2024-01-02 |
588,694 |
2024-01-02 |
9,595 |
Premium* |
|
Regulus Therapeutics Inc. |
RGLS |
10% Owner |
|
0 |
2019-05-07 |
2,052,454 |
Premium* |
|
Surface Oncology, Inc. |
SURF |
10% Owner |
2018-04-23 |
0 |
2018-04-23 |
3,312,877 |
Premium* |
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
10% Owner |
2017-10-10 |
0 |
2017-10-10 |
4,909,956 |
Premium* |
|
Appian Corp |
APPN |
10% Owner |
2017-11-20 |
0 |
2018-02-13 |
2,031 |
Premium* |
|
Elastic N.v. |
ESTC |
10% Owner |
2018-10-10 |
0 |
2018-10-10 |
2,197,503 |
Premium* |
|
Genocea Biosciences, Inc. |
GNCA |
10% Owner |
2019-02-14 |
0 |
2019-06-24 |
7,225,676 |
Premium* |
|
Trevi Therapeutics, Inc. |
TRVI |
10% Owner |
2019-05-09 |
0 |
2019-05-09 |
4,438,562 |
Premium* |
|
Nightstar Therapeutics Plc |
NITE |
Director, 10% Owner |
2019-06-07 |
0 |
2019-06-07 |
0 |
Premium* |
|
Mirum Pharmaceuticals, Inc. |
MIRM |
10% Owner |
2019-07-22 |
0 |
2019-07-22 |
4,186,243 |
Premium* |
|
Cloudflare, Inc. |
NET |
10% Owner |
2019-09-17 |
4,059,376 |
2019-09-17 |
0 |
Premium* |
|
Novavax Inc |
NVAX |
|
2024-06-12 |
50,470 |
|
0 |
Premium* |
|
Enliven Therapeutics Ord Shs |
ELVN |
Director |
2022-02-23 |
229,224 |
2022-02-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
223 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 9 of 9
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MIRM |
Mirum Pharmaceuticals, In... |
10% Owner |
|
2019-07-22 |
4 |
B |
$15.00 |
$6,750,000 |
I/I |
450,000 |
4,186,243 |
1.5 |
- |
|
EPZM |
Epizyme, Inc. |
Director |
|
2013-11-14 |
4 |
B |
$19.04 |
$7,018,527 |
I/I |
357,000 |
357,000 |
2.25 |
- |
|
ADAP |
Adaptimmune Therapeutics ... |
Director |
|
2017-03-27 |
4 |
B |
$0.70 |
$9,009,000 |
I/I |
12,870,000 |
72,139,000 |
2.25 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
10% Owner |
|
2017-10-10 |
4 |
B |
$17.00 |
$9,350,000 |
I/I |
550,000 |
4,909,956 |
1.5 |
- |
|
GNCA |
Genocea Biosciences, Inc. |
10% Owner |
|
2019-06-24 |
4 |
B |
$3.50 |
$9,999,997 |
I/I |
2,857,142 |
7,225,676 |
1.5 |
- |
|
EPZM |
Epizyme, Inc. |
Director |
|
2016-01-12 |
4 |
B |
$9.00 |
$9,999,999 |
I/I |
1,111,111 |
5,854,351 |
2.25 |
- |
|
ARDX |
Ardelyx Inc |
Director |
|
2016-01-13 |
4 |
B |
$10.00 |
$10,000,000 |
I/I |
1,000,000 |
1,901,869 |
2.25 |
- |
|
APPN |
Appian Corp |
10% Owner |
|
2017-11-27 |
4 |
S |
$19.49 |
$11,101,894 |
I/I |
(569,620) |
0 |
0 |
- |
|
ADAP |
Adaptimmune Therapeutics ... |
Director |
|
2018-03-27 |
4 |
B |
$1.92 |
$11,500,200 |
I/I |
6,000,000 |
79,978,672 |
2.25 |
- |
|
ARDX |
Ardelyx Inc |
Director |
|
2016-07-18 |
4 |
B |
$8.73 |
$13,333,338 |
I/I |
1,527,301 |
2,665,519 |
2.25 |
- |
|
TSRO |
Tesaro, Inc. |
Director |
|
2012-07-03 |
4 |
B |
$13.50 |
$14,999,999 |
I/I |
1,111,111 |
11,499,255 |
2.25 |
- |
|
MRSN |
Mersana Therapeutics, Inc... |
Director |
|
2017-07-03 |
4 |
B |
$15.00 |
$15,000,000 |
I/I |
1,000,000 |
8,140,138 |
2.25 |
- |
|
MRSN |
Mersana Therapeutics, Inc... |
Director |
|
2019-03-05 |
4 |
B |
$4.00 |
$15,000,000 |
I/I |
3,750,000 |
11,890,138 |
2.25 |
- |
|
CLVS |
Clovis Oncology, Inc. |
10% Owner |
|
2011-11-21 |
4 |
B |
$13.00 |
$17,111,887 |
I/I |
1,316,299 |
3,419,671 |
1.5 |
- |
|
MM |
Millennial Media Inc |
10% Owner |
|
2012-10-29 |
4 |
S |
$13.44 |
$21,478,252 |
I/I |
(1,597,787) |
8,196,614 |
0 |
- |
|
TRVI |
Trevi Therapeutics, Inc. |
10% Owner |
|
2019-05-09 |
4 |
B |
$10.00 |
$25,000,000 |
I/I |
2,500,000 |
4,438,562 |
1.5 |
- |
|
ADAP |
Adaptimmune Therapeutics ... |
Director |
|
2018-09-07 |
4 |
B |
$1.67 |
$25,000,500 |
I/I |
15,000,000 |
12,000,000 |
2.25 |
- |
|
ARDX |
Ardelyx Inc |
Director |
|
2015-06-05 |
4 |
B |
$10.70 |
$29,999,997 |
I/I |
2,803,738 |
1,401,869 |
2.25 |
- |
|
MEDI |
Medimmune Inc |
Vice Chairman, CEO & President |
|
2007-06-01 |
4 |
D |
$58.00 |
$34,762,590 |
D/D |
(599,355) |
0 |
0 |
- |
|
TSRO |
Tesaro, Inc. |
Director |
|
2016-03-18 |
4 |
B |
$35.19 |
$49,999,993 |
I/I |
1,420,858 |
710,429 |
2.25 |
- |
|
APPN |
Appian Corp |
10% Owner |
|
2017-11-20 |
4 |
S |
$19.49 |
$54,971,857 |
I/I |
(2,820,516) |
0 |
0 |
- |
|
NITE |
Nightstar Therapeutics Pl... |
Director |
|
2019-06-07 |
4 |
D |
$25.50 |
$169,894,566 |
I/I |
(6,662,532) |
0 |
0 |
- |
|
TSRO |
Tesaro, Inc. |
Director |
|
2019-01-22 |
4 |
D |
$75.00 |
$781,641,600 |
I/I |
(10,421,888) |
0 |
0 |
- |
|
223 Records found
|
|
Page 9 of 9 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|